NovoCure (NVCR) Return on Capital Employed (2015 - 2026)
NovoCure (NVCR) posted Return on Capital Employed of 27.05% for Q2 2026, up 14.66% sequentially from 31.69% in Q1 2026, and up 767.0% YoY from 3.12% in Q2 2025.
NovoCure (NVCR) Return on Capital Employed (2015 - 2026) Analysis & Trends
NovoCure has reported Return on Capital Employed for 12 years, with the latest figure at 27.05% in Q2 2026.
- Quarterly Return on Capital Employed rose 767.0% year-over-year to 27.05% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 27.05% (up 767.0% YoY) and the FY2025 annual result came in at 19.24%, up 1977.0% from the prior year.
- Return on Capital Employed advanced to 27.05% in Q2 2026 per NVCR's latest filing, from 31.69% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 4.43% in Q1 2022 and troughed at 35.89% in Q4 2024.
- A 5-year average of 21.81% and a median of 22.25% in 2023 frame the typical range for Return on Capital Employed.
- The widest YoY moves for Return on Capital Employed: up 1800 bps in 2025, down 1617 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 8.74% in 2022, then sank by 175 bps to 24.08% in 2023, then slumped by 49 bps to 35.89% in 2024, then soared by 50 bps to 17.89% in 2025, then slumped by 51 bps to 27.05% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 27.05%, 31.69%, and 17.89% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.08% |
| 10 | NovoCure | 1.99 Bn | 1.55 Bn | 142.48 Mn | -27.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.05% |
| Mar 31, 2026 | -31.69% |
| Dec 31, 2025 | -17.89% |
| Sep 30, 2025 | -33.50% |
| Jun 30, 2025 | -34.72% |
| Mar 31, 2025 | -33.27% |
| Dec 31, 2024 | -35.89% |
| Sep 30, 2024 | -32.96% |
| Jun 30, 2024 | -18.55% |
| Mar 31, 2024 | -22.00% |
| Dec 31, 2023 | -24.08% |
| Sep 30, 2023 | -22.51% |
| Jun 30, 2023 | -18.74% |
| Mar 31, 2023 | -14.40% |
| Dec 31, 2022 | -8.74% |
| Sep 30, 2022 | -6.81% |
| Jun 30, 2022 | -5.28% |
| Mar 31, 2022 | -4.43% |
| Dec 31, 2021 | -4.49% |
| Sep 30, 2021 | -0.90% |